Bierbaum, Veronika
Bobeth, Christoph
Roessler, Martin
Gerken, Michael
Tol, Kees Kleihues-van
Reissfelder, Christoph
Fürst, Alois
Günster, Christian
Dröge, Patrik
Ruhnke, Thomas
Klinkhammer-Schalke, Monika
Schmitt, Jochen
Schoffer, Olaf
Funding for this research was provided by:
Gemeinsame Bundesausschuss (01VSF17020, 01VSF17020, 01VSF17020, 01VSF17020, 01VSF17020, 01VSF17020)
Technische Universität Dresden
Article History
Received: 28 October 2022
Accepted: 22 November 2023
First Online: 6 January 2024
Declarations
:
: As stated in the main text of the manuscript,“Data were pseudonymized using pseudonymization procedures on the patient and the hospital level, respectively. Pseudonymization on both levels was conducted by WIdO. The data was encrypted for transfer and subsequently analyzed at the Center for Evidence-based Healthcare (ZEGV) of the TU Dresden, Germany. The WiZen study was approved by the ethics committee of the TU Dresden (approval number: EK95022019, IRB 00001473, OHRP IORG0001076). Data processing and analyses were conducted in line with the Declaration of Helsinki and the General Data Protection Regulation of the European Union.”
: Does not apply.
: VB, CB, JS, and OS work at a university hospital with certified cancer centers, and MR worked there in the past. In addition, they received funding from the Innovation Committee of the Federal Joint Committee during the conduct of the study. Unrelated to this study, JS reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU, Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He also participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. Unrelated to this study, OS worked as a paid consultant for Novartis. He is also a member of the certification commission “Skin Cancer Centers” of the German Cancer Society and a member of the expert panel in the project "Development of Criteria for the Evaluation of Certificates and Quality Seals in Accordance with Sect. 137a (3) Sentence 2 Number 7 SGB V" for the Institute for Quality Assurance and Transparency in Health Care (IQTIG). The other authors declare that they have no conflict of interest.